Ciesielski, Katharine M.
Mann, Pavan K.
Mandelbaum, Rachel S.
Klar, Maximilian
Roman, Lynda D.
Wright, Jason D.
Matsuo, Koji https://orcid.org/0000-0002-6232-8701
Funding for this research was provided by:
Ensign Endowment for Gynecologic Cancer Research
University of Southern California
Article History
Received: 2 September 2023
Accepted: 1 February 2024
First Online: 22 March 2024
Declarations
:
: All were unrelated to the work: research grant, Merck, royalties, UpToDate (J.D.W.); consultant, AstraZeneca, CooperSurgical, KLS Martin (M.K.); consultant, Cardiff Oncology, NutCracker, participation in the Steering Committee for the Global Coalition of Adaptive Research (L.D.R.); none for others.
: University of Southern California Institutional Review Board (HS-16-00481) approved the study.
: Not applicable.
: Not applicable.
: Not applicable.
: The manuscript’s corresponding author (K.M.) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. The Nationwide Ambulatory Surgery Sample is a part of the Healthcare Cost and Utilization Project by the Agency for Healthcare Research and Quality and is the source of the de-identified data used; and the program has not verified and is not responsible for the statistical validity of the data analysis or the conclusions derived by the study team.